Cassava Sciences Inc vs KLA Corp. — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while KLA Corp. trades at $204.94 (market cap $261.92B). The key difference: KLA Corp. is far larger — about 5485.2× Cassava Sciences Inc's market cap, and KLA Corp. pays a 0.46% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | KLAC | |
|---|---|---|
Market Cap | $47.75M | $261.92B |
Sector | Health | Technology |
52-Week High | $4.64 | $301.71 |
52-Week Low | $0.87 | $84.39 |
Enterprise Value | -$34.93M | $263.17B |
Dividend Yield | — | 0.46% |
Trailing returns across standard periods
Latest headlines on both assets
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →KLA designs and manufactures yield-management and process-monitoring diagnostic and control systems for the semiconductor manufacturing industry. The systems are used to analyze the manufacturing process at various steps in a semiconductor's development. The firm's laser-scanning products are used for wafer qualification, process monitoring, and equipment monitoring. KLA also provides inspection tools and systems for optical metrology and e-beam metrology.
Read more on KLAC →